Gemigliptin

Generic Name
Gemigliptin
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C18H19F8N5O2
CAS Number
911637-19-9
Unique Ingredient Identifier
5DHU18M5D6
Background

Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.

Associated Conditions
Type 2 Diabetes Mellitus
Associated Therapies
-

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-12-09
Last Posted Date
2014-07-14
Lead Sponsor
LG Life Sciences
Target Recruit Count
28
Registration Number
NCT02004587
Locations
🇩🇪

CRS Clinical Research Services, Kiel, Schleswig-Holstein, Germany

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

Phase 3
Completed
Conditions
Interventions
First Posted Date
2013-11-21
Last Posted Date
2016-04-19
Lead Sponsor
LG Life Sciences
Target Recruit Count
219
Registration Number
NCT01990469

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-04-08
Last Posted Date
2014-12-30
Lead Sponsor
LG Life Sciences
Target Recruit Count
30
Registration Number
NCT01825850
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath